News & Updates

Show Multimedia Only

Glaucoma tied to increased risk of Alzheimer's, related dementias

Glaucoma tied to increased risk of Alzheimer's, related dementias

Individuals with glaucoma, particular those diagnosed at older ages, are prone to developing Alzheimer’s disease (AD), vascular dementia (VaD), and all-cause dementia (ACD), reports a study.

01 Mar 2024

Interactive multistage robotic positioner developed for intraoperative MRI-guided stereotactic neurosurgery

Interactive multistage robotic positioner developed for intraoperative MRI-guided stereotactic neurosurgery

A joint multidisciplinary team of researchers from the Chinese University of Hong Kong (CUHK), the University of Hong Kong (HKU), University College London, and Johns Hopkins University has developed an interactive, multistage robotic positioner for intraoperative MRI-guided stereotactic neurosurgery aimed at treating patients with neurological diseases, such as brain tumours and Parkinson’s disease.

01 Mar 2024

Low-dose epinephrine does not reduce blood loss during TURP but lowers hypotension risk

Low-dose epinephrine does not reduce blood loss during TURP but lowers hypotension risk

Low-dose epinephrine does not reduce blood loss during TURP but lowers hypotension risk

In patients undergoing transurethral resection of prostate (TURP), treatment with low-dose epinephrine falls short of reducing blood loss during the operation but appears to minimize the incidence of hypotension, as reported in a study.

Major adverse kidney events common among young people undergoing CKRT

Major adverse kidney events common among young people undergoing CKRT

Almost two-thirds of youths undergoing continuous kidney replacement therapy (CKRT) have major adverse kidney events 90 days after CKRT initiation (MAKE-90), with risk factors including cardiac comorbidity, time to CKRT initiation, and liberation patterns, according to a study.

Team approach to care optimizes bariatric surgery outcomes

Team approach to care optimizes bariatric surgery outcomes

Applying the collaborative prescribing (CP) practice framework in the care of patients who have undergone bariatric surgery in Singapore is viable and helps the patients achieve the best possible outcomes, reports a research team from the Singapore General Hospital.

SBRT on par with HART in limited-stage small-cell lung cancer

SBRT on par with HART in limited-stage small-cell lung cancer

Stereotactic body radiotherapy (SBRT) is a safe and effective alternative to hyperfractionated accelerated radiotherapy (HART) in the treatment of limited-stage small-cell lung cancer (LS-SCLC), suggests a recent study.

29 Feb 2024

Pembrolizumab plus lenvatinib effective against nonclear cell RCC

Pembrolizumab plus lenvatinib effective against nonclear cell RCC

Pembrolizumab (pembro) plus lenvatinib (lenva) provides durable antitumour activity in patients with advanced nonclear cell renal cell carcinoma (nccRCC) and has a manageable safety profile, according to the results of the phase II KEYNOTE-B61 study.

29 Feb 2024

Cilostazol, ticagrelor more cost-effective than standard therapy for acute ischaemic stroke

Cilostazol, ticagrelor more cost-effective than standard therapy for acute ischaemic stroke

Use of CYP2C19 genotype-guided antiplatelet therapy with cilostazol or ticagrelor as a substitute to clopidogrel is more cost-effective than conventional antiplatelet therapy for patients with acute minor ischaemic stroke and high-risk transient ischaemic attack, suggests a China study.

29 Feb 2024

Early-onset oculomotor neuropathy ups dementia risk

Early-onset oculomotor neuropathy ups dementia risk

Adults who develop ocular motor cranial neuropathy (OMCN), particularly at a younger age, are at greater risk of having dementia, reveals a study.

29 Feb 2024

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

TKI-ICI combo offers hope for prostate cancer patients with poor prognosis

A combination of the TKI* cabozantinib and ICI** atezolizumab improved progression-free survival (PFS) in men with metastatic castration-resistant prostate cancer (mCRPC) with measurable extrapelvic nodal or visceral metastasis who progressed on prior novel hormonal therapy (NHT), findings from the phase III CONTACT-02 trial have shown.

29 Feb 2024

Something went wrong.